Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [757]

T cell engineering breakthrough sidesteps need for viruses in gene-editing

T cell engineering breakthrough sidesteps need for viruses in gene-editing

Treating skin cancer with HPV vaccines

Treating skin cancer with HPV vaccines

Cancer-causing virus HTLV-1 changes DNA loops to 'affect tens of thousands of genes'

Cancer-causing virus HTLV-1 changes DNA loops to 'affect tens of thousands of genes'

Poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent

Poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent

Study examines first birth cohort to receive HPV vaccine: The vaccine works

Study examines first birth cohort to receive HPV vaccine: The vaccine works

ASCO 2018: Interim results from clinical trial of immunotherapy for glioblastoma show significant clinical benefit

ASCO 2018: Interim results from clinical trial of immunotherapy for glioblastoma show significant clinical benefit

Women more likely to use other preventive health services after mammography

Women more likely to use other preventive health services after mammography

Personalised cancer vaccine may increase long-term survival in patients with deadly brain cancer

Personalised cancer vaccine may increase long-term survival in patients with deadly brain cancer

DNA-based vaccine treatment for colorectal cancer to undergo first human study

DNA-based vaccine treatment for colorectal cancer to undergo first human study

Erectile dysfunction drugs and flu vaccine may fight cancer after surgery

Erectile dysfunction drugs and flu vaccine may fight cancer after surgery

More from ecancer